Table 1 Baseline characteristics of the study population.

From: Statistical and machine learning methods for analysis of multiplex protein data from a novel proximity extension assay in patients with ST-elevation myocardial infarction

 

Total population (n = 48)

Patients receiving bivalirudin during PPCI(n = 16)

Age, years, mean ± standard deviation

60 ± 12

66 ± 9

Male, gender, n (%)

38 (79)

11 (69)

Smokers, n (%)

31 (65)

10 (63)

Hypertension, n (%)

23 (48)

11 (69)

Body Mass Index, kg/m2, median (interquartile range)

27 (25–30)

25 (23–27)

Diabetes, n (%)

5 (10)

3 (19)

Total plasma cholesterol, mmol/l, median (interquartile range)

5.0 (4.3–5.6)

4.9 (4.4–6.3)

Previous myocardial infarction, n (%)

6 (13)

1 (6)

Previous stroke or TIA, n (%)

1 (2)

1 (6)

  1. More details have been provided by Funck-Jensen et al.6.
  2. PPCI = primary percutaneous coronary intervention; TIA = Transient ischaemic attack.
Back to article page